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Abstract
Focal myositis (FM) is a rare inflammatory myopathy characterized by a painful swelling of a 
skeletal muscle. The lower limb is the most common site for FM, but it has also been reported 
in the abdomen, forearm, neck, and tongue musculature. Some conservative treatments such 
as non-steroidal anti-inflammatory drugs, physiotherapy, and steroids can relieve muscle pain 
and its minor complications. This report describes a patient who had shoulder pain and was 
diagnosed with FM in the left trapezius muscle with an excellent response to high-intensity 
laser therapy.
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Introduction
Focal myositis (FM) is a rare, benign myopathy 
characterized by a focal inflammatory pseudo-tumor of 
the skeletal muscle, which was initially reported in 1977 
by Heffner et al.1 It is uncertain whether FM is a unique 
clinical entity or a rare form of polymyositis.2 It presents 
itself as a painful swelling of a muscle that enlarges rapidly 
and simulates a soft tissue neoplasm.3 The leg is the most 
common site of FM, but it has also been reported in 
the abdomen, forearm, neck, and tongue musculature.3 
Indeed, FM is recognized as a generalized inflammatory 
muscle disease, which may initially present itself focally, 
involving one limb at its onset. For example, Lederman 
described 3 patients with weakness of a single-limb 
myositis which progressed to generalized polymyositis.4 
Barwick and Walton also described unilateral quadriceps 
weakness progressed to diffuse weakness.5
The laboratory findings of FM, including the erythrocyte 
sedimentation rate (ESR) and serum creatine kinase 
(CK) are usually normal. Computerized tomography 
(CT) reveals diffuse homogenous enlargement and fatty 
infiltration of the affected muscles.6 Magnetic resonance 
imaging (MRI) is one of the most useful diagnostic 
methods that show the abnormal signal intensity of the 
involved muscles.7 In some cases of FM, evidence of 
denervation has been reported in electromyography 
(EMG).2
We describe a case of FM in a rare place, namely the 
upper trapezius muscle, which was treated with a high-
power laser with an excellent response. 
Case Report
A 55-year-old woman was referred to the sports medicine 
clinic with severe shoulder pain. The pain had started in 
the left supraclavicular region spreading to the neck, ear, 
and occiput about 6 weeks before the treatment. It had 
been felt during the day and night and had caused her 
to wake up at times. She had been unable to sleep on the 
shoulder and sometimes even the pain had intensified 
by relying on the chair. The intensity of her pain was to 
the extent that she had been unable to perform her daily 
activities effectively. The score of the pain was 9 on the 
visual analog scale (VAS). There was not any history of 
trauma or special disease. However, she had had a history 
of falling about 6 years before the treatment, leading to 
a clavicle fracture which had been treated with an arm 
sling. Such systemic symptoms as general weakness, fever, 
and weight loss were not mentioned. In drug history, she 
had taken Aspirin 80 mg daily for 10 years. 
Physical examination revealed prominence area in 
the left supraclavicular region without evidence of 
redness or erythema. The left sternoclavicular joint was 
more prominent compared to the other side that seems 
compatible with the past clavicle fracture, but there was 
not any history of trauma in the area of pain. There 
was severe tenderness in the upper trapezius muscle, 
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especially around its insertion into the clavicle and also 
in the left acromioclavicular joint. No nodule or mass was 
palpated. All ranges of shoulder active or passive motion 
were normal and pain free; however, the arm abduction 
and forward flexion were a little painful. The special tests 
of the glenohumeral joint, such as Job, Lift-off, Belly-
Press, Neer, Hawkins, and O’Brian tests were normal. The 
patient felt pain through the cross arm adduction test, the 
head rotation to the right and the length-tension test of 
the left upper trapezius muscle. The strength of the left 
trapezius muscle was not assessed due to the pain but on 
the right side, it was 5/5 by the muscle manual test. 
Regarding the symptoms and the findings of physical 
examination, a shoulder and cervical MRI and also some 
laboratory tests were requested. In the cervical MRI, an 
intervertebral disc protrusion was seen at the level of C5-6 
without compressive effects on the nerve root, which was 
not compatible with the patient’s symptoms.
There was a poorly defined, high-signal area in the 
attachment of trapezius muscle to the clavicle at the 
coronal and sagittal T2 sequences and also in the proton 
density fat suppress sequences. There was also an obvious 
isointense area in the T1 sequence of the shoulder MRI 
too (Figures 1 and 2).
The findings from the laboratory tests of collagen 
vascular diseases were normal. They included ANA 
(anti-nuclear antibody), anti double-stranded DNA, 
anti JO1, RF (rheumatoid factor), ESR,  and CRP 
(C-reactive protein). Other tests such as CBC (complete 
blood count), LDH (lactate dehydrogenase), ALP 
(alkaline phosphatase), CPK (creatine phosphokinase), 
ALT (alanine aminotransferase), AST (aspartate 
aminotransferase), BUN (blood urea nitrogen), 
Creatine and U/A (urinary analysis) were also normal. 
Consequently, collagen vascular disease, rhabdomyolysis 
or other systemic diseases were considered fewer. In order 
to recognize the exact cause of the symptoms and signs, 
a muscle biopsy was advocated, but the patient rejected 
the offer. We prescribed 100 mg diclofenac daily for 7 
days, but unfortunately, the pain did not subside. As the 
next step, after 2 weeks, we decided to inject 40 mg Depo-
Medrol (methylprednisolone acetate) plus 1 cc lidocaine 
2% in the maximum point of tenderness in the trapezius 
muscle. The pain and swelling were eliminated after 3 
days slightly (the VAS declined to 8 /10). The patient was 
observed closely after injection. Given the weak response 
to oral Diclofenac and the injected Depo-Medrol, laser 
therapy started after 4 weeks. A high-intensity laser 
(ND-YAG, 1064 nm Physiomed, Belgium) was used 
through 8 sessions, every other day, after obtaining the 
informed consent. The pain was significantly reduced 
after 3-4 sessions (the VAS declined to 3/10). At the end 
of the eighth session, there was a dramatic decrease in 
the VAS score (1/10), and finally, the pain completely 
disappeared after 1 week. After three months, the patient 
was completely painless. The second shoulder MRI (with 
gadolinium contrast) was requested. The lesion was 
smaller than before (Figures 3 and 4). After 6 months, she 
had no pain or tenderness in that area and was able to 
perform all daily tasks without any pain.
A B
Figure 1. Sagittal view of the shoulder MRI; (A) PD, (B) T1. Figure 3. Sagittal view of the shoulder MRI; (A) T1, (B) PD.





 Journal of Lasers in Medical Sciences  Volume 10, Number 4, Autumn 2019348
Discussion
The case of this study was FM of a trapezius muscle with 
an excellent response to high-intensity laser therapy 
(HILT). Two cases of myositis in the trapezius muscle 
have also been reported, which responded very well to 
steroid therapy. One of them was isolated myositis that 
led to muscle atrophy and drop head syndrome and was 
recognized by clinical manifestations and histopathologic 
features.8 The other one was a case of myositis in the 
left and right trapezius muscles with eye involvement.9 
Therefore, to the best of our knowledge, this study gains 
significance by presenting a rare case report of isolated 
FM in the left upper trapezius muscle with a wonderful 
response to a high-intensity laser. 
The laser as a new modality has been used in the 
treatment of a variety of acute and chronic musculoskeletal 
injuries, degenerative conditions, and wound healing.10 
Ramos et al studied the effect of laser photobiomodulation 
on muscle injury in rats. They used male Wistar rats 
(200 g) and performed tibialis muscle elongation by 
passive stretching of the anterior tibial muscle attached 
to a weight corresponding to 150% of the body mass of 
the animal. The stretching continued for 20 minutes and 
with a 3 minutes’ rest the second traction was repeated 
for 20 minutes again. Cytokines, tumor necrosis factor-α 
(TNF-α), interleukin-1β (IL-1β), IL-6, and IL-10, edema, 
and C-reactive protein (CRP) levels were determined in 
their tibialis anterior muscles. Finally, they concluded 
that the laser reduced skeletal muscle edema as well as 
cytokines, and CRP then led to a significant reduction in 
inflammatory markers.11 
Through a study guided by Carvalho et al, 15 male rats 
were distributed into three groups: control group (C), 
induced myositis without treatment (MI), and treated 
induced myositis (MT), for seven days. The induction 
of acute myositis was done with 1% acetic acid by the 
intramuscular route. The rats in the MT group had daily 
treatment through the GaAs (gallium arsenide) laser, 
with 904 nm length and 45 mW peak power with 3 J/
cm2, applied for 5 minutes to the animals’ right posterior 
limb. In the MT group, there was a statistically significant 
decrease in the number of inflammatory cells (P < 0.05) 
compared to the MI group. In addition, the MT group 
showed an increase in the fibroblastic proliferation 
compared to C and MI groups (P < 0.01). Also, significant 
edema regression (P = 0.040) in the MT group achieved 
similar results in rats.12 Moreover, the positive effects 
of laser therapy have been seen in a few cases of 
dermatomyositis.13
HILT which includes higher intensity laser radiation 
is a new, painless, and powerful modality and it has 
shown significant results concerning pain reduction in 
the osteoarthritis and other musculoskeletal disorders.14 
However, the evidence of the effectiveness of the high-
intensity laser in musculoskeletal pain is limited because 
the number of related studies is low. Alayat et al assessed 
the effect of the ND YAG laser on knee osteoarthritis. 
They concluded the pulsed Nd:YAG laser combined with 
glucosamine/chondroitin sulfate (GCS) and exercise were 
more effective than GCS plus exercise (GCS + EX) and 
exercise alone in the treatment of knee osteoarthritis.15 
HILT has satisfactory effects on reducing pain. HILT 
through photo-chemical, photo-thermal, and photo-
mechanical actions has many therapeutic benefits 
including antalgic, anti-edema, and bio-stimulating 
effects.16,17 Another advantage of HILT, especially the 
neodymium-doped yttrium aluminum garnet (ND YAG) 
laser, is its greater power and depth of penetration in deep 
tissues.18 
Therefore, our case showed that HILT was an effective 
method in the pain relief of myositis. Its effectiveness 
can be due to its analgesic and anti-inflammatory effects. 
Nevertheless, more extensive studies are needed to prove 
the efficacy of HILT and compare the low-level laser with 
HILT.
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